Journal Logo

News

ASH 2019

What to Know About This Year's Conference

Lacorte, Sarah

doi: 10.1097/01.COT.0000612736.05096.db
  • Free
ASH 2019
ASH 2019:
ASH 2019

The 61st ASH Annual Meeting and Exposition will be held in Orlando, Fla., Dec. 7-10, 2019. Attendees will have access to thousands of scientific abstracts highlighting cutting-edge research in hematology. This conference is an opportunity to enhance your practice through educational programs while networking with leaders in the field. Check out highlights from the upcoming conferences to help you make the most of your time at ASH.

Program Details

Attendees will have a plethora of educational programs at their disposal:

  • Scientific Spotlight Sessions
    • Monday, Dec. 9: Redox Biology in Thrombosis
  • Education Spotlight Sessions
    • Sunday, Dec. 8: Point-Counterpoint: Curative Therapies for SCD - Does it Make More Sense to Target the Root Cause Than All the Downstream Events
    • Monday, Dec. 9: Molecular Hematopathology Tumor Board
    • Monday, Dec. 9: Diving Into Rare Childhood Leukemias
    • Monday, Dec. 9: Is Chemoimmunotherapy for CLL on Life Support? (Point- Counterpoint)
    • Monday, Dec. 9: Street Drugs: Emerging Hematologic Complications of Illicit Drug Use
  • Continuing Conversations With the Speakers
    • Saturday, Dec. 7: Genome Editing for Transplantation and Cellular Therapies
    • Saturday, Dec. 7: Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches
    • Sunday, Dec. 8: Chromatin Structure in Development and Disease
    • Sunday, Dec. 8: Ex Vivo Bioengineering of Blood Products for Transfusion
  • Meet the Scientist
    • Saturday, Dec. 7: Cell-based Therapeutics with Colleen Delaney, MD, MSc
    • Saturday, Dec. 7: Links between Complement Activation and Thrombosis with Wolfram Ruf, MD
    • Saturday, Dec. 7: TP53 Action and the Consequences of p53 Mutation in Acute Myeloid Leukemia with Scott W. Lowe, PhD
    • Sunday, Dec. 8: Aptamers as Rapid Onset and Rapidly Reversible Antithrombotic Agents with Bruce A. Sullenger, PhD
    • Sunday, Dec. 8: Artificial Intelligence in Pathology: Opportunities and Challenges with Kun-Hsing Yu, MD, PhD
    • Sunday, Dec. 8: Blood Cell Fate Decisions: Insights from Single-cell RNA-seq with Merav Socolovsky, MBBS, PhD
    • Sunday, Dec. 8: Clonal Dynamics in Chronic Lymphocytic Leukemia with Catherine J. Wu, MD
    • Sunday, Dec. 8: Ferroportin in Erythrocytes: Importance for Iron Homeostasis and its Role in Infection with Tracey Rouault, MD
    • Sunday, Dec. 8: PROTACs and Protein Degradationb with Craig M. Crews, PhD
    • Sunday, Dec. 8: Three-D Models for Megakaryopoiesis and Platelet Production with Alessandra Balduini, MD
  • How I Treat: Bringing Science to Clinical Dilemmas
    • Saturday, Dec. 7: Approach to Diagnosis and Management of Patients with Congenital Platelet Disorders, Speaker: Jorge Di Paola, MD
    • Saturday, Dec. 7: Hypereosinophilia: An Approach to Diagnosis and Management, Speaker: Andreas Reiter, MD
    • Saturday, Dec. 7: Implementation of Direct Oral Anticoagulant Reversal Agents in the Critical Care Setting, Speaker: Marc Carrier, MD
    • Saturday, Dec. 7: MRD Testing to Guide Treatment Decisions in CLL, Speaker: Jennifer Woyach, MD
    • Saturday, Dec. 7: Strategy for Diagnosis and Management of Bone Marrow Failure Syndromes, Speaker: Stella M. Davies, PhD, MBBS, MRCP
    • Saturday, Dec. 7: Update on Complement Inhibition in PNH, Atypical HUS, and other Hemolytic Anemias, Speaker: Peter Hillmen, MD, PhD
    • Saturday, Dec. 7: What's New in the Diagnosis and Treatment of HLH?, Speaker: Nancy Berliner, MD
    • Sunday, Dec. 8: Approach to the Patient with Microangiopathic Hemolytic Anemia, Speaker: Adam Cuker, MD, MS
    • Sunday, Dec. 8: Defining Treatment Strategies for MDS/MPN Overlap Syndromes, Speaker: Aaron T. Gerds, MD, MS
    • Sunday, Dec. 8: How to Interpret Next Generation Sequencing Panels in Patients with CHIP and Hematolymphoid Neoplasms, Speaker: David P. Steensma, MD
    • Sunday, Dec. 8: Monoclonal Gammopathies of Cutaneous, Neuropathic, and Renal Significance, Speaker: Angela Dispenzieri, MD
  • Global Capacity-Building Showcase: Check out this digital poster session highlighting research and capacity-building initiatives in lower- and middle-income countries.

Special Interest Sessions

Smaller sessions provide the opportunity for ASH's various communities to focus on specific topics of interest.

  • ASH Choosing Wisely Campaign: 2019 ASH Choosing Wisely Champions
    • Monday, Dec. 9, 2019: ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system.
  • ASH Choosing Wisely Campaign: The ASH-ASPHO Pediatric Choosing Wisely List
    • Monday, Dec. 9, 2019: The Choosing Wisely initiative aims to help physicians and patients engage in conversations to reduce overuse of tests and procedures and supports physician efforts to help patients make smart and effective care choices.

New to ASH?

For medical students and residents attending ASH for the first time, an all-day trainee event called “ASH-a-Palooza” is designed to introduce the many resources that ASH can provide in a more relaxed environment.

  • When: Friday, Dec. 6, 12:30 p.m. to 5:00 p.m.
  • Where: Topgolf (located across from the North Building of the Orange County Convention Center on Universal Boulevard. A courtesy shuttle will be provided between the Orange County Convention Center West Building and Topgolf).
  • What: At “Ash-a-Palooza” attendees will have the opportunity to participate in a new educational experience that will offer “a relaxed, open learning environment for trainees in a festival-like setting with multiple opportunities for micro learning.” The event is free and does not require registration, but attendance will be limited on a first-come, first-served basis.

The event will include several interactive learning opportunities. “ASH Talks” will be presented on the Topgolf driving range. Rapid-fire learning sessions (“Blood Drops”) will allow the audience to move easily between each presentation. Speakers will either present one slide for 5 minutes or 20 slides changing automatically every 15 seconds. Trainees will be able to enjoy food during breaks and can visit information booths to learn about the latest opportunities in hematology.

Visit the Exhibit Hall & Pick Up HemOnc Times

Looking for the latest technology and research in hematology/oncology? Take time to explore the Exhibit Hall to learn more about the latest opportunities and innovations from more than 250 exhibitors.

HemOnc Times
HemOnc Times:
HemOnc Times

HemOnc Times, a supplement to Oncology Times, not only highlights the latest breakthroughs, but is also your go-to source for insights and tools geared to enhancing your hematology/oncology practice and research. Visit Booth #1101 to pick up the latest copy!

And stay current on the latest articles, videos, podcasts, and more from HemOnc Times here: bit.ly/HemOncTimes

Join Us on Social Media at #ASH19!

Join Oncology Times in Orlando! We will be providing live updates on cutting-edge research throughout the conference. Follow us on Twitter (@OncologyTimes) and Facebook (@OncologyTimesNews) to learn about the latest hematology/oncology breakthroughs!

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Home  Clinical Resource Center
Current Issue       Search OT
Archives Get OT Enews
Blogs Email us!